9930
|
ETCTN
|
A Phase I Trial of MEDI-570 in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL) Follicular Variant and Angioimmunoblastic T-Cell Lymphoma (AITL)
|
Adult CIRB - Early Phase Emphasis
|
Available to Open
|
|
9938
|
ETCTN
|
Phase I clinical trial of VX-970 in combination with the topoisomerase I inhibitor irinotecan in patients with advanced solid tumors
|
Adult CIRB - Early Phase Emphasis
|
Available to Open
|
|
9944
|
ETCTN
|
Phase 2 Study of M6620 (VX-970) in Combination with gemcitabine versus gemcitabine alone in Subjects with Platinum-Resistant Recurrent Ovarian or Primary Peritoneal Fallopian Tube Cancer
|
Adult CIRB - Early Phase Emphasis
|
Available to Open
|
|
9947
|
ETCTN
|
A Randomized Phase 2 Trial of Cisplatin/Gemcitabine with or without M6620 (VX-970) in Metastatic Urothelial Carcinoma
|
Adult CIRB - Early Phase Emphasis
|
Completed
|
|
9948
|
ETCTN
|
Phase 1 Dose Escalation and Expansion Cohort of Carboplatin and Gemcitabine with or without M6620 (VX-970) in First or Second Recurrence Platinum-Sensitive Epithelial Ovarian, Peritoneal, and Fallopian Tube Cancer
|
Adult CIRB - Early Phase Emphasis
|
Available to Open
|
|
9950
|
ETCTN
|
A Phase I Study of M6620 (VX-970) in Combination with Cisplatin and XRT in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC; SDC 10060121)
|
Adult CIRB - Early Phase Emphasis
|
Available to Open
|
|
9952
|
ETCTN
|
Phase 1 Trial to Determine the Recommended Phase 2 Dose (RP2D) of M6620 (VX‐970) When Combined with Whole Brain Radiotherapy (WBRT) in Patients with Brain Metastases from Lung Cancer
|
Adult CIRB - Early Phase Emphasis
|
Completed
|
|
9974
|
ETCTN
|
A phase II study of olaparib plus cediranib in combination with standard therapy for small cell lung cancer
|
Adult CIRB - Early Phase Emphasis
|
Completed
|
|
9979
|
ETCTN
|
Phase 1 and Pharmacology Study of Oral 5-iodo-2-pyrimidinone-2-deoxyribose (IPdR) as a Prodrug for IUdR-Mediated Tumor Radiosensitization in Brain Metastases
|
Adult CIRB - Early Phase Emphasis
|
Available to Open
|
|
9984
|
ETCTN
|
A Randomized Phase 2 Study of cediranib in Combination with olaparib versus olaparib alone in men with metastatic castration resistant prostate cancer
|
Adult CIRB - Early Phase Emphasis
|
Available to Open
|
|